Hemoglobin-based oxygen carriers: A long road from bench to bedside

Pediatric Hematology and Oncology

Volumn 24, Issue 6, 2007, Pages 461-463

  Quirolo, Keith ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROCARBON; HEMOGLOBIN; OXYGEN; RECOMBINANT HEMOGLOBIN;

BLOOD TRANSFUSION; HEART DISEASE; HUMAN; HYPERTENSION; INFECTION RISK; INJURY; ISCHEMIA; LETTER; MORBIDITY; ORTHOPEDIC SURGERY; SAFETY; SICKLE CELL ANEMIA; VASOCONSTRICTION;

ANEMIA, SICKLE CELL; ANIMALS; BLOOD LOSS, SURGICAL; BLOOD SUBSTITUTES; BLOOD TRANSFUSION; CATTLE; CLINICAL TRIALS, PHASE III; HEMOGLOBINS; HUMANS; HYPERTENSION; SPECIES SPECIFICITY; SPLEEN;

EID: 34548132050     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010701481100     Document Type: Letter

References (10)

1. Stefan DC, Uys R, Wessels G . Hemopure transfusion in a child with severe anemia. Pediatric Hematology and Oncology. 2007;24:269-273.
2. Janssen van Doorn K, Diltoer M, Servotte S, et al . Transfusion of polymerized bovine haemoglobin in a patient with sickle cell anaemia and severe allo-immunization: a case report. Acta Clin Belg. 2001;56:191-194.
3. Raff JP, Dobson CE, Tsai HM. Transfusion of polymerised human haemoglobin in a patient with severe sickle-cell anaemia. Lancet. 2002;360:464-465.
4. Lanzinger MJ, Niklason LE, Shannon M, Hill SE. Use of hemoglobin raffimer for postoperative life-threatening anemia in a Jehovah's Witness. Can J Anaesth. 2005;52:369-373.
5. Agrawal YP, Freedman M, Szczepiorkowski ZM. Long-term transfusion of polymerized bovine hemoglobin in a Jehovah's Witness following chemotherapy for myeloid leukemia: a case report. Transfusion. 2005;45:1735-1738.
6. Jahr JS, Stewart LM, MacKenzie C, Bourke D, Williams JP. Pivotal phase III study: safety of polymerized bovine hemoglobin (HBOC-201, HEMOPURE®) as compared to RBC in patients undergoing orthopedic surgery. Anesthesiology. 2002;96:A243.
7. Northfield Laboratories, Inc. Pivotal phase III trial assessing the safety and efficacy of PolyHeme®, its human hemoglobin based oxygen-carrying red blood cell substitute in the treatment of severely injured and bleeding patients when blood is needed but not immediately available. Corporate news release, 2006.
8. Stern, SA. Low-volume fluid resuscitation for presumed hemorrhagic shock: helpful or harmful? Curr Opin Crit Care. 2001;7:422-430.
9. Fitzpatrick CM, Savage SA, Kerby JD, Clouse WD, Kashyap VS. Resuscitation with a HBOC causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage. J Am Coll Surg. 2004;199:693-701.
10. Klein HG. The prospects for red-cell substitutes. N Engl J Med. 2000;342:1666-1668.